Why you should consider travel health insurance
| | | | | | In this edition: The newest players in longevity, and why you should probably buy travel health insurance. | | | | | | PHOTO ILLUSTRATION: PETER CROWTHER | | | | The women of the longevity industry. In the high-profile pursuit of lifespans extending to 100 and beyond, men have been the faces of the movement. That is starting to change with the rise of an increasingly prominent group of female scientists, entrepreneurs and influencers. In a field dominated by "longevity bros," they could be called the "longevity ladies." | | Cancer and the Manhattan Project. People who grew up in the 1940s, '50s or '60s around Coldwater Creek in St. Louis County–near where uranium was processed during WWII–faced a heightened risk of cancer, new research suggests. | | Juul Labs' e-cigarettes get FDA nod. Federal regulators will allow the vaping company's e-cigarettes–and tobacco and menthol-flavored refills, to remain on the U.S. market, according to people familiar with the matter. The decision breathes new life into Juul after a federal ban in 2022 pushed it to the brink of bankruptcy. | | | | CONTENT FROM: Deloitte | | America's Minerals Challenge Demands Coordinated Response | The U.S. depends on foreign suppliers for 100% of 12 critical minerals and more than 50% of 29 others, threatening economic security. President Donald Trump's National Energy Dominance Council proposes a three-part action plan: boost domestic mining, strengthen international partnerships and improve market transparency to reduce import reliance and enhance supply chain resilience. Read More | | | | | | | 27% | The premium increase sought by the biggest Affordable Care Act health plan in Illinois for next year, among a flurry of big rate hike requests to states. | | | | | | "It's a normal part of aging that our veins could become damaged. The vast majority of the time it's not a big deal." | — Dr. Gregory Magee, chief of vascular and endovascular surgery at NYU Langone Health in New York City, regarding President Trump's diagnosis with chronic venous insufficiency. | | | | | | | | ILLUSTRATION: JON KRAUSE | | | | Why you should buy travel health insurance. Few things can wreck a vacation like an unexpected trip to the doctor or emergency room, especially in a foreign country. Credit-card and U.S. health-insurance providers may offer some coverage abroad. But it's critical to read the fine print ahead of a trip to see exactly what is—and isn't—covered. | | A lower-energy energy drink? Liquid Death, the six-year-old brand best known for selling water in large beer cans emblazoned with dripping skulls, is moving into the energy drinks aisle. The hook? Its offering, Sparkling Energy, will be less loaded with caffeine than most new entrants. | | | | | PHOTO: GEORGE FREY/REUTERS | | | | Direct-to-consumer drugs. Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price—a move that follows the Trump administration's pressure on the industry to cut drug prices. Eliquis has a list price of $606 for a 30-day supply; the discounted cash price will be $346 a month. | | Wall Street shrugs off threats of pharma tariffs. Since President Trump said that imported drugs would face a 200% levy, investors have been cautiously celebrating. They focused on a grace period of a year to a year and a half that Trump floated. With more time to prepare, pharma companies may barely feel the sting. | | Private equity makes bet on biopharma. Private-equity firms Bain Capital and Kohlberg are leading a new multibillion-dollar investment in PCI Pharma Services, a company that specializes in helping biopharma companies bring new drugs to market. The deal values PCI at $10 billion, including debt. | | | This newsletter was compiled by the WSJ's Health & Science team. Follow us on X @WSJHealth and @WSJScience. Email us by replying to this newsletter. | | | | | | |